Alcohol

Ethanol (C₂H₅OH)

BoozeLiquorSpiritsHoochSauceJuiceBrewDrinkEtOHEthyl Alcohol
Open Interactive Guide →

Ethanol is a central nervous system depressant produced through fermentation of sugars by yeast or through synthesis. It is the psychoactive ingredient in beverages including beer, wine, and distilled spirits. Alcohol is one of the most widely consumed psychoactive substances globally and has both acute intoxication effects and potential for chronic health complications and dependence.

How It Works

Ethanol acts primarily as an allosteric modulator of GABA-A receptors, enhancing GABAergic inhibitory neurotransmission. It also inhibits glutamatergic NMDA receptors and affects monoamine systems including dopamine and serotonin. At higher doses, it depresses the brainstem and can cause profound CNS depression. The mechanism of action produces dose-dependent effects ranging from mild disinhibition at low doses to sedation, unconsciousness, and respiratory depression at high doses.

Legal Status

Legal for adults (age 21+ in US, 18+ in most countries); production, distribution, and sale are heavily regulated. Illegal to purchase or consume for minors in most jurisdictions. DUI laws criminalize driving under the influence.

Dosage Guide (Oral)

LevelAmount (standard drinks (US: 14g ethanol))
Threshold0.25-0.5 standard drinks (3-7g ethanol) — measurable effects begin
Light1-2 standard drinks — mild euphoria, slight impairment of fine motor control, slight increase in reaction time
Common2-4 standard drinks (28-56g ethanol) — noticeable intoxication, emotional disinhibition, impaired judgment, slurred speech, reduced coordination
Strong4-8 standard drinks (56-112g ethanol) — significant impairment, difficulty walking, slurred speech, blackouts possible, potential for alcohol poisoning risk
Heavy8+ standard drinks (112g+ ethanol) — severe intoxication, risk of alcohol poisoning, loss of consciousness, potentially fatal respiratory depression

Note: Threshold and dosing highly variable based on body weight, tolerance, food consumption, and gender. Women show higher BAC at equivalent doses due to lower water content and reduced gastric alcohol dehydrogenase. Tolerance develops rapidly with regular use. BAC calculation: (drink volume in mL × alcohol % ÷ 1000 × 0.789) ÷ (body weight in kg × 0.58 for males, 0.49 for females). One standard drink raises BAC approximately 0.015-0.025% in average adults; metabolism: ~7g per hour (one standard drink per hour).

Organ System Impacts

cardiovascular — Moderate
Acute: vasodilation causing initial drop in blood pressure followed by rebound increases; potential arrhythmias (atrial fibrillation), increased heart rate, and myocardial depression at high doses. Chronic: hypertension, cardiomyopathy, increased risk of stroke, thromboembolism, and sudden cardiac death. Alcohol has a biphasic dose-response; moderate consumption may have cardioprotective effects while heavy use is cardiotoxic.
neurological — Dangerous
Acute: CNS depression, impaired cognition, reduced reaction time, ataxia, slurred speech, blackouts (anterograde amnesia), seizure risk in predisposed individuals. Chronic: permanent cognitive impairment, dementia, cerebellar degeneration (ataxia, dysarthria), polyneuropathy, Wernicke-Korsakoff syndrome (if thiamine deficient), increased stroke risk, and altered brain morphology.
ocular — Low
Acute: blurred vision, reduced accommodation, nystagmus, decreased pupillary light response, impaired depth perception. Chronic: cataracts, optic neuropathy, and increased glaucoma risk. Acetaldehyde accumulation in heavy users may contribute to ocular damage.
dermatological — Low
Acute: flushing, erythema, increased perspiration, and facial edema. Chronic: spider angiomas, palmar erythema, poor wound healing, increased bruising, acne exacerbation, and rosacea. Alcohol may trigger or worsen psoriasis and other inflammatory skin conditions.
respiratory — High
Acute: respiratory depression (particularly with high doses or in combination with other CNS depressants), aspiration risk during unconsciousness, suppressed cough reflex. Chronic: increased infections, aspiration pneumonia in alcoholics, and potential sleep apnea. Heavy acute intoxication can cause fatal respiratory arrest.
hepatic — Dangerous
Acute: mild hepatic inflammation and transaminase elevation. Chronic: fatty liver (hepatic steatosis), alcoholic hepatitis, cirrhosis, hepatic fibrosis, and hepatocellular carcinoma. Acetaldehyde (primary metabolite) is directly hepatotoxic. Cirrhosis is irreversible; chronic liver disease increases infection risk and metabolic dysfunction. Heavy consumption dramatically increases risk.
hematological — Moderate
Acute: minimal effects on blood composition. Chronic: anemia (from malnutrition, GI bleeding, bone marrow suppression), thrombocytopenia (platelet dysfunction and reduced production), leukopenia, impaired clotting factor synthesis, coagulopathy, and increased bleeding risk. Direct toxic effects on bone marrow and nutritional deficiencies (B12, folate) contribute.
renal — Moderate
Acute: increased urination from inhibited ADH (antidiuretic hormone), leading to dehydration and electrolyte loss (potassium, magnesium). Chronic: electrolyte abnormalities, kidney disease, hyperuricemia and gout, and potential acute kidney injury in heavy users. Alcohol-induced hypertension contributes to progressive renal damage.
gastrointestinal — High
Acute: stomach irritation, increased acid production, nausea, vomiting, potential gastric ulceration if repeated exposure. Chronic: gastritis, peptic ulcer disease, GI bleeding, esophageal varices (from cirrhosis), esophageal and gastric cancers, malabsorption syndromes, and pancreatitis. Alcohol damages the gastric mucosa and increases Helicobacter pylori infection risk.
musculoskeletal — Low
Acute: myalgia (muscle pain), potential rhabdomyolysis with very high doses. Chronic: alcoholic myopathy (muscle weakness and atrophy), osteoporosis (reduced bone density from impaired calcium absorption and hormonal effects), increased fracture risk, poor wound healing, and impaired muscle recovery. Malnutrition and reduced physical activity in heavy users contribute.

Effects

Desired Effects

Negative Effects

Rare but Serious

Drug Interactions

Opioids (heroin, morphine, oxycodone, codeine) — dangerous

Both alcohol and opioids are CNS depressants. Combined use potentiates respiratory depression, sedation, and overdose risk. Significantly increases overdose mortality. Threshold for fatal respiratory depression is substantially lower. Both impair judgment and coordination. Alcohol may increase opioid absorption and peak levels.

Benzodiazepines (diazepam, alprazolam, lorazepam, flunitrazepam) — dangerous

Severe CNS depression with combined use. Potentiates sedation, respiratory depression, and loss of consciousness. Greatly increases overdose risk and potential for fatal respiratory depression. Both impair memory and judgment. Combination is a leading cause of drug-related death. Synergistic GABAergic effects.

GHB (gamma-hydroxybutyrate) — dangerous

Both are CNS depressants. Combination produces severe CNS depression, profound sedation, unconsciousness, respiratory depression, and potential death. Greatly increases overdose risk. GHB's dose-response curve is already narrow; alcohol interaction significantly increases toxicity. Combined use associated with sexual assault due to incapacitation.

Cocaine — dangerous

Cocaine stimulates while alcohol depresses the CNS, masking intoxication and leading to excessive consumption of both. Combined cardiotoxic effects increase risk of heart attack, arrhythmias, and stroke. Liver metabolizes both substances; combined metabolism produces cocaethylene, which is more cardiotoxic than either drug alone. Increased risk of sudden cardiac death.

MDMA (Ecstasy) — dangerous

Alcohol is dehydrating; MDMA also causes dehydration and hyperthermia. Combined use dramatically increases risk of severe dehydration, dangerous hyperthermia, and electrolyte imbalance. Both increase heart rate and blood pressure; combination increases cardiovascular stress and arrhythmia risk. Impairs judgment regarding fluid intake and body temperature monitoring.

Methamphetamine — dangerous

Methamphetamine stimulates while alcohol depresses, masking intoxication and promoting excessive use of both. Combination strains cardiovascular system (increased heart rate, blood pressure); greatly increases risk of heart attack, stroke, and sudden cardiac death. Combined neurotoxicity may increase long-term brain damage. Impairs decision-making.

Acetaminophen (Tylenol) — moderate

Alcohol increases risk of hepatotoxicity from acetaminophen, particularly in chronic drinkers with compromised liver function. Even normal doses of acetaminophen combined with alcohol can cause liver damage. Risk increases significantly with higher acetaminophen doses or regular alcohol use. Alcohol induces CYP2E1 which metabolizes acetaminophen to toxic N-acetyl-p-benzoquinone imine.

NSAIDs (ibuprofen, naproxen, aspirin) — moderate

Alcohol increases risk of GI bleeding and ulcer formation when combined with NSAIDs. Both irritate the gastric mucosa; combined effect is synergistic. Increases risk of acute kidney injury. Chronic combination use increases GI cancer risk. Aspirin interaction may impair platelet function further.

Antidepressants (SSRIs, tricyclics, SNRIs) — moderate

Alcohol potentiates CNS depression. Some antidepressants may increase alcohol sensitivity. Combined use impairs judgment and increases accident risk. Alcohol may worsen depression. Tricyclic antidepressants have anticholinergic effects amplified by alcohol. Both affect serotonin; serotonin syndrome possible with certain combinations.

Detection Times

Ethanol clears rapidly but metabolic markers (EtG, PEth) can indicate use over longer periods.

Breathalyzer

Detects current blood alcohol concentration in real-time. Detection window: up to 1 days.

Urine (EtG)

Ethyl glucuronide (EtG) metabolite test detects recent drinking. Detection window: up to 3 days.

Blood

Direct ethanol testing or PEth marker for chronic use. Detection window: up to 1 days.

Hair

EtG in hair can indicate chronic alcohol use. Detection window: up to 90 days.

Harm Reduction Tips

Withdrawal Symptoms

Severity: Dangerous

Minor withdrawal: 6-24 hours (tremors, anxiety, nausea). Seizure risk: 12-48 hours. Delirium tremens: 48-96 hours (peak danger). Full resolution: 5-7 days. Protracted withdrawal (mood, sleep, cravings): weeks to months.

Physical

Psychological

Emergency Information

Call 911 If:

Warning Signs

What To Do

  1. Call emergency services (911 in US, 999 in UK, 112 in EU) immediately
  2. If person is conscious and sitting: keep them upright and monitor breathing
  3. If person is unconscious: place in recovery position (on left side, head tilted back, one leg bent for stability) to prevent aspiration of vomit
  4. Do not leave the person alone at any time
  5. Monitor breathing and pulse; be ready to perform CPR if needed
  6. If vomiting: keep person on their side; wipe mouth clear
  7. Loosen tight clothing, particularly around neck and chest
  8. If seizures occur: move away furniture/hazards; do not restrain; protect head; time the seizure; call 911 if lasting more than 5 minutes
  9. Cover person with blanket if shivering (but not if overheating)
  10. Do not give caffeine, cold showers, or other 'remedies'; these are ineffective and potentially dangerous
  11. Provide emergency responders with accurate information about consumption (amount, time, type, other substances)
Harm reduction information only. This is not medical advice. If you are experiencing a medical emergency, call 911 immediately.